449

Compound name
Gilteritinib
Alt Name
ASP2215
ASP-2215
Xospata
Compound Image
Gilteritinib.png
SMILES
CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5
MW
552.70
Brutto
C29H44N8O3
InChI
InChI=1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34
InChI Key
GYQYAJJFPNQOOW-UHFFFAOYSA-N
Approval Jurisdiction
2018 FDA 2019 EMA 2021 China
Approved for clinical use
Acute Myeloid Leukemia FLT3 Mutant
CAS
1254053-43-4
PubChem CID
49803313
Action
FLT3; RTKs
Approved Drug List
1
Commercial Vendor
Astellas Pharma